✦ LIBER ✦

A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes

✍ Scribed by A. H. Barnett; D. M. Anderson; S. Shelley; R. Morgan; D. R. Owens

Book ID: 109042084
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 157 KB
Volume: 6
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1462-8902.2004.00321.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and adverse effects of low-dose

Efficacy and adverse effects of low-dose nateglinide in early type 2 diabetes: comparison with acarbose in a crossover study

✍ Toyoyoshi Uchida; Junko Kawai; Yoshio Fujitani; Ryuzo Kawamori; Hirotaka Watada; 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 187 KB

ORIGINAL ARTICLE: Pioglitazone improveme

ORIGINAL ARTICLE: Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study

✍ Leonard C. Glass; Kenneth Cusi; Rachele Berria; Roberta Petz; Eugenio Cersosimo; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Differential effect of pioglitazone (PGZ

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study

✍ Bernard Chappuis; Monika Braun; Christoph Stettler; Sabine Allemann; Peter Diem; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

Lowering of postprandial lipids in indiv

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

✍ B. Eliasson; D. Möller-Goede; K. Eeg-Olofsson; C. Wilson; J. Cederholm; P. Fleck 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 311 KB

Effects of glipizide GITS and glibenclam

Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes

✍ Eugene H. Go; Marinella Kyriakidou-Himonas; Michael Berelowitz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

Effects of aspirin on serum C-reactive p

Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial

✍ M. M. C. Hovens; J. D. Snoep; Y. Groeneveld; M. Frölich; J. T. Tamsma; M. V. Hui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB